Genotypic analysis of tumor suppresser genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas

Laryngoscope

Volumn 108, Issue 10, 1998, Pages 1553-1556

  Henderson, Ying C ^a   Wang, Eric ^a   Clayman, Gary L ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Mutation; p53; PTEN MMAC1; Squamous cells

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; DNA SEQUENCE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; POINT MUTATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; GENES, P53; GENES, TUMOR SUPPRESSOR; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0031668767     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199810000-00024     Document Type: Article

References (17)

1. Pavelic ZP, Gluckman JL. The role of p53 tumor suppressor gene in human head and neck tumorigenesis. Acta Otolaryngol 1997;527:21-4.
2. Field JK, Pavelic ZP, Spandidos DA, Stambrook PJ, Jone AS, Gluckman JL. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1993;119:1118-22.
3. Kiuru A, Servomaa K, Grenman R, Pulkkinen J, Rytomaa T. p53 mutations in human head and neck cancer cell lines. Acta Otolaryngol 1997;529:237-10.
4. Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992;52:5997-6000.
5. Liu TJ, Zhang W, Taylor DL, Roth JA, Goepfert H, Clayman GL. Growth suppression of human head and neck cancer cells by the introduction of a wild type p53 gene via a recombinant adenovirus. Cancer Res 1994;54:3662-67.
6. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1 at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-62.
7. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997;275:1943-47.
8. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-7.
9. Myers MP, Stolarov JP, Eng C, et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A 1997;94:9052-57.
10. Racz T, Sack PG, Taylor DL, Schantz SP. Natural killer cell lysis of head and neck cancer. Arch Otolaryngol Head Neck Surg 1989;115:1322-28.
11. Sack PG, Parnes SM, Gallick GE, et al. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res 1988;48:2858-66.
12. Lehman TA, Bennett WP, Metcalf RA, et al. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 1991;51:4090-96.
13. Lamb P, Crawford L. Characterization of the human p53 gene. Mol Cell Biol 1986;6:1379-85.
14. Hu GY, Zhang W, Deisseroth AB. P53 gene mutations in acute myelogenous leukaemia. Br J Haematol 1992;81:489-94.
15. Hollstein M, Shomer B, Greenblatt M, et al. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 1996;24:141-46.
16. Bockmuhl U, Petersen S, Schmidt S, et al. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 1997; 57:5213-16.
17. Cairns P. Okami K, Halachimi S, et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 1997;57:4997-5000.